Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease

Journal of Clinical Gastroenterology

Volumn 36, Issue 2, 2003, Pages 120-125

  Pugas Carvalho, Ana Teresa ^a   Siqueira Elia, Celeste Carvalho ^a   Pereira de Souza, Heitor Siffert ^a   Pinheiro Elias, Paulo Roberto ^a   Lopes Pontes, Eduardo ^a   Pitanga Lukashok, Hannah ^a   Dias de Freitas, Fernanda Cristina ^a   Lapa e Silva, José Roberto ^a  

^a Apt 101 ^*

Author keywords

Eosinophils; Inflammatory bowel disease; Intestinal mucosa

Indexed keywords

ALKALINE PHOSPHATASE; INTERLEUKIN 5 ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; AGED; ALLERGIC DISEASE; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DEGRANULATION; ENTERITIS; EOSINOPHIL; FEMALE; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IRRITABLE COLON; LAMINA PROPRIA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TH2 CELL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AZO COMPOUNDS; BLOOD PROTEINS; COLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; ILEITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-5; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINS; RIBONUCLEASES;

EID: 0037310764     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200302000-00006     Document Type: Article

References (25)

1. Rothenberg ME. Eosinophilia. N Engl J Med 1998;338:1592-60.
2. Walsh RE, Gaginella TS. The eosinophil in inflammatory bowel disease. Scand J Gastroenterol 1991;26:1217-24.
3. Gleich GJ, Adolphson CR. The eosinophilic leukocyte: structure and function. Adv Immunol 1986;39:177-253.
4. Weller PF. Human eosinophils. J Allergy Clin Immunol 1997;100:283-7.
5. Bischoff S, Mayer J, Nguyen QT, et al. Immunohistologic assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol 1999;94:3521-9.
6. Ohtsuka Y, Suzuki R, Nagata S, et al. Chronic oral antigen exposure induces lymphocyte migration in anaphylactic mouse intestine. Pediatr Res 1998;44:791-7.
7. Chung HL, Hwang JB, Kwon YD, et al. Deposition of eosinophil-granule major basic protein and expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the mucosa of the small intestine in infants with cow's milk-sensitive enteropathy. J Allergy Clin Immunol 1999;103:1195-201.
8. Desreumaux P, Bloget F, Seguy D, et al. Interleukin 3, granulocyte-macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis. Gastroenterology 1996;110:768-74.
9. Dvorak AM, Osage JE, Monahan RA, et al. Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation and injury to smooth muscles and the autonomic nervous system. Hum Pathol 1980;11:620-34.
10. Sarin SK, Malhotra V, Gupta S, et al. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 1987;32:363-7.
11. Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996;28:1-13.
12. Jeziorska M, Haboubi N, Schofield P, et al. Distribution and activation of eosinophils in inflammatory bowel disease using an improved immunohistochemical technique. J Pathol 2001;194:484-92.
13. Truelove SC, Witts LF. Cortisone in ulcerative colitis: a final report on a therapeutic trial. BMJ 1955;2:1041-8.
14. Harvey RF, Bradshwal JM. A simple index of Crohn's disease activity. Lancet 1980;i:514.
15. Tai P-C, Spry CJ, Peterson C, et al. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984,309:182-4.
16. Weller PF. The immunology of eosinophils. N Engl J Med 1991;324:1110-8.
17. Venge P. Human eosinophil granule proteins: structure, function and release. In: Immunopharmacology of eosinophils. Ed: Academic Press Limited,1993;:43-52.
18. Venge P, Bystöm J. Molecules in focus: eosinophil cationic protein (ECP). Int J Biochem Cell Biol 1998,30:433-7.
19. Raab Y, Fredens K, Gerdin B, et al. Eosinophil activation in ulcerative colitis. Studies on mucosal release and localisation of eosinophil granule constituents. Dig Dis Sci 1998;43:1061-70.
20. Foster PS, Hogan SP, Ramsay AJ, et al. Interleukin 5 deficient abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195-201.
21. Moqbel R. Eosinophils, cytocines, and allergic inflammation. Ann NY Acad Sci 1994;725:223-33.
22. Lorentz A, Schwengberg S, Mierke C. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol 1999;29:1496-503.
23. Schuermann GM, Aber-Bishop AE, Facer P, et al. Altered expression of cell adhesion molecules in uninvolve, gut in inflammatory bowel disease. Clin Exp Immunol 1993;94:341-7.
24. Hallgren R, Colombel JF, Dahl R, et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohistochemical localisation of granulocyte granule constituents. Am J Med 1989;86:56-63.
25. Desreumaux P, Brandt E, Gambiez L, et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 1997;113:118-26.